Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Clin Cancer Res. 2018 Aug 21;25(1):73–79. doi: 10.1158/1078-0432.CCR-18-0110

Table 1.

Demographics of patients in the intention-to-treat analysis of the efficacy of iniparib added to radiation and temozolomide.

Baseline Characteristics: All Patients (N = 81)
Age (years):
    Median (range)
    >70
    50–70
    <50
58 (27–81)
10 (12%)
54 (67%)
17 (21%)
Gender: no. (%)
    Male
51 (63)
Race: no. (%)
    Black or African American
    White
    Unknown
1 (1)
77 (95)
4 (4)
Ethnic Group: no. (%)
    Hispanic or Latino
    Not Hispanic or Latino
    Unknown
1 (1)
74 (91)
6 (7)
KPS: no. (%)
    100
    90
    80
    70
    60
9 (11)
40 (49)
22 (27)
8 (10)
2 (2)
Surgical Procedure: no. (%)
    Craniotomy
    Biopsy
77 (95)
4 (5)
MGMT: no. (%)
    Methylated:
    Unmethylated:
    Unknown:
29 (36)
37 (46)
15 (18)
Mini Mental Score: median (Range) 29 (22 – 30)
Diagnosis: no. (%)
    Glioblastoma Multiforme
81 (100)
Anticonvulsant Usage: no. (%)
    Yes
    No
64 (79)
17 (21)